HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Eriko Takatori Selected Research
Eriko Takatori Research Topics
Disease
12
Neoplasms (Cancer)
09/2019 - 01/2011
8
Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2021 - 04/2010
7
Ovarian Neoplasms (Ovarian Cancer)
05/2021 - 11/2010
5
Carcinoma (Carcinomatosis)
12/2021 - 06/2012
4
Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2018 - 03/2013
2
Mucinous Adenocarcinoma (Mucinous Carcinoma)
12/2021 - 02/2014
2
Disease Progression
08/2017 - 10/2012
2
Neutropenia
05/2014 - 08/2013
1
Colorectal Neoplasms (Colorectal Cancer)
09/2019
1
Ovarian Epithelial Carcinoma
09/2019
1
Lung Neoplasms (Lung Cancer)
09/2019
1
Proteinuria
08/2018
1
Fistula
08/2018
1
Hypertension (High Blood Pressure)
08/2018
1
Intestinal Perforation
08/2018
1
Neoplasm Metastasis (Metastasis)
08/2018
1
Thrombosis (Thrombus)
08/2018
1
Surgical Blood Loss
12/2016
1
Lymphatic Metastasis
04/2015
1
Nausea
03/2015
1
Vomiting
03/2015
1
Ascites
07/2014
1
Adenocarcinoma
04/2014
1
Anemia
08/2013
1
Fatigue
08/2013
1
Thrombocytopenia (Thrombopenia)
08/2013
1
Diarrhea
08/2013
1
Constipation
10/2012
1
Carcinoid Tumor (Carcinoid)
10/2012
1
Adenoid Cystic Carcinoma (Cylindroma)
01/2012
1
Takotsubo Cardiomyopathy
01/2012
1
Body Weight (Weight, Body)
01/2011
1
Hypersensitivity (Allergy)
11/2010
1
Endometrioid Carcinoma
05/2010
1
Drug-Related Side Effects and Adverse Reactions
04/2010
Drug/Important Bio-Agent (IBA)
9
Irinotecan (Camptosar)
FDA Link
Generic
08/2017 - 04/2010
7
Platinum
IBA
05/2021 - 01/2011
6
Carboplatin (JM8)
FDA Link
Generic
08/2018 - 11/2010
5
Paclitaxel (Taxol)
FDA Link
Generic
08/2018 - 06/2012
4
Bevacizumab (Avastin)
FDA Link
05/2021 - 01/2015
4
taxane
IBA
08/2017 - 01/2011
3
Cisplatin (Platino)
FDA Link
Generic
05/2010 - 04/2010
2
1-dodecylpyridoxal (PLD)
IBA
08/2017 - 05/2014
2
liposomal doxorubicin (Doxil)
FDA Link
08/2017 - 05/2014
2
squamous cell carcinoma-related antigen
IBA
07/2016 - 04/2015
2
Antineoplastic Agents (Antineoplastics)
IBA
01/2013 - 06/2012
1
olaparib
IBA
05/2021
1
niraparib
IBA
05/2021
1
4-boronic acid benzophenone
IBA
09/2019
1
Antigens
IBA
07/2016
1
Carcinoembryonic Antigen
IBA
07/2016
1
Dexamethasone (Maxidex)
FDA Link
Generic
03/2015
1
Palonosetron (Aloxi)
FDA Link
03/2015
1
Antiemetics
IBA
03/2015
1
Dihydrotachysterol (AT 10)
IBA
07/2014
1
Triamcinolone Acetonide (Azmacort)
FDA Link
Generic
07/2014
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
04/2014
1
Everolimus
FDA Link
01/2014
1
TOR Serine-Threonine Kinases
IBA
01/2014
1
nedaplatin
IBA
08/2013
1
Biological Products
IBA
07/2013
1
Gemcitabine
FDA Link
01/2013
1
Peptide YY
IBA
10/2012
1
Etoposide (VP 16)
FDA Link
Generic
01/2011
1
Docetaxel (Taxotere)
FDA Link
11/2010
1
beta-Galactosidase (Lactaid)
IBA
05/2010
1
Fluorouracil (Carac)
FDA Link
Generic
05/2010
1
Pharmaceutical Preparations
IBA
05/2010
1
Doxorubicin (Adriamycin)
FDA Link
Generic
05/2010
Therapy/Procedure
9
Therapeutics
12/2021 - 11/2010
9
Drug Therapy (Chemotherapy)
12/2021 - 08/2013
6
Neoadjuvant Therapy
12/2016 - 04/2010
4
Hysterectomy
12/2016 - 02/2014
2
Chemoradiotherapy
05/2021 - 01/2012
2
Combination Drug Therapy (Combination Chemotherapy)
08/2018 - 01/2011
1
Adjuvant Chemotherapy
05/2021
1
TP protocol
08/2018
1
Brachytherapy
08/2018
1
Radiotherapy
08/2018
1
Operative Time
12/2016
1
Drug Tapering
05/2014
1
Cesarean Section (Caesarean Section)
01/2012